AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine

slide icon

Join Us for a Webinar!

Crystal Structure Determination in Solid Form Drug Development


Dr. Steef Boerrigter, Senior Research Scientist, AMRI

1:00pm EST on Tuesday, September 22, 2020

COVID-19: Updates from AMRI

slide icon

We’ve got API Development and Manufacturing Down to an Exact Science

Access More than 240 Commercial APIs

slide icon

We’ve got Drug Product Down to an Exact Science

Tour our New Aseptic Pre-filled Syringe Line

AMRI Express

Request a quote for:

  • Analytical Services
  • in vitro DMPK Services
  • Aseptic Fill Finish Services
  • Antimicrobial discovery testing services

Go to AMRI Express!

Submit Samples For Analytical Testing

Learn more about the sample studies we perform and reports we provide.

Read More Here

Global Drug Product Solutions

Learn more about our integrated drug development and manufacturing expertise.

Read the Infographic


Navigate the Journey From Pipeline to Portfolio With a Trusted Partner.

See our solutions

The Latest from AMRI


AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine

September 3, 2020

AMRI’s Albuquerque Facility Is Set to Provide Sterile Fill/Finish Manufacture of AstraZeneca’s AZD1222 Vaccine Candidate Through 2021   ALBANY, N.Y.–(BUSINESS...


Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprie...

August 13, 2020

La Jolla, California–(Newsfile Corp. – August 13, 2020) –  Tryp Therapeutics Inc. (“Tryp” or the “Company”), a clinical-stage pharmaceutical company...


ViralClear Pharmaceuticals Partners with AMRI on the Manufacture of Merimepodib API in ...

July 8, 2020

July 08, 2020 10:30 AM Eastern Daylight Time WESTPORT, Conn.–(BUSINESS WIRE)–ViralClear Pharmaceuticals, Inc. (ViralClear), supported by Albany Molecular Research Inc., (AMRI), a...


BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology ...

June 11, 2020

DANVILLE, Calif.–(BUSINESS WIRE)–BryoLogyx Inc. today announced it has entered into two agreements with Neurotrope, Inc. (Nasdaq: NTRP) to acquire Neurotrope’s...

Ready to develop a successful partnership?

Let's Get Started